You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健帆生物(300529.SZ):2022年度淨利預降10%-30%
格隆匯 01-11 19:58

格隆匯1月11日丨健帆生物(300529.SZ)公佈2022年年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利8.38億元-10.77億元,比上年同期下降10%-30%;扣除非經常性損益後的淨利潤盈利7.72億元-10.11億元,比上年同期下降11%-32%。

報吿期內,國際形勢複雜嚴峻,國內經濟增速放緩,同時疫情在全國各地散發,經銷商資金緊張及購貨能力下降,公司經營活動面臨很大的挑戰。成本方面,報吿期內原材料價格持續上漲,且公司金鼎、湖北等產業園陸續投入使用,導致產品生產成本持續增加;同時,公司加大人才引進和研發投入,銷售費用、研發費用同比有較大幅度增長。基於上述影響,預計公司2022年度業績較去年同期有所下降。

公司2021年度非經常性損益金額為6009.70萬元,預計2022年度非經常性損益金額約為6607萬元,主要系閒置資金購買理財產品的收益和收到政府補助的收入、公司捐贈支出等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account